Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (111-120 of 239) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|March 1, 1977
Methyltestosterone therapy in hereditary angioedemaA L Sheffer, D T Fearon, K F Austen
Advances in Experimental Medicine and Biology|August 30, 2018
Stromal Cells in the Tumor MicroenvironmentAlice E Denton, Edward W Roberts, Douglas T Fearon
Immunity|July 1, 1997
Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulinR M Tooze, G M Doody, D T Fearon
The Journal of Clinical Investigation|August 1, 1983
Genetic regulation of a structural polymorphism of human C3b receptorW W Wong, J G Wilson, D T Fearon
Cancer Immunology Research|May 22, 2023
T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profileRan Yan, Philip Moresco, Bruno Gegenhuber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase functionM R Daha, K F Austen, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytesJ K Czop, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1976
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertaseM R Daha, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factorM R Daha, K F Austen, D T Fearon
The Journal of Allergy and Clinical Immunology|September 1, 1981
Clinical and biochemical effects of stanozolol therapy for hereditary angioedemaA L Sheffer, D T Fearon, K F Austen
Pageof 24

Showing results (111-120 of 239) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|March 1, 1977
Methyltestosterone therapy in hereditary angioedemaA L Sheffer, D T Fearon, K F Austen
Advances in Experimental Medicine and Biology|August 30, 2018
Stromal Cells in the Tumor MicroenvironmentAlice E Denton, Edward W Roberts, Douglas T Fearon
Immunity|July 1, 1997
Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulinR M Tooze, G M Doody, D T Fearon
The Journal of Clinical Investigation|August 1, 1983
Genetic regulation of a structural polymorphism of human C3b receptorW W Wong, J G Wilson, D T Fearon
Cancer Immunology Research|May 22, 2023
T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profileRan Yan, Philip Moresco, Bruno Gegenhuber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase functionM R Daha, K F Austen, D T Fearon
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytesJ K Czop, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1976
C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertaseM R Daha, D T Fearon, K F Austen
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1978
Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factorM R Daha, K F Austen, D T Fearon
The Journal of Allergy and Clinical Immunology|September 1, 1981
Clinical and biochemical effects of stanozolol therapy for hereditary angioedemaA L Sheffer, D T Fearon, K F Austen
Pageof 24